Zobrazeno 1 - 10
of 971
pro vyhledávání: '"Aballea, A"'
Autor:
Michal Pochopien, Jakub Wladyslaw Dziedzic, Samuel Aballea, Emilie Clay, Iwona Zerda, Mondher Toumi, Borislav Borissov
Publikováno v:
Journal of Market Access & Health Policy, Vol 12, Iss 2, Pp 35-57 (2024)
Objective: Currently there are no disease-specific approved therapies for non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH); however, several treatments are under development. This study aimed to estimate the cost-effectivenes
Externí odkaz:
https://doaj.org/article/fc390ad500dc455d81017d8d018d9062
Autor:
Etchecopar-Etchart, Damien, Yon, Dong Keon, Wojciechowski, Piotr, Aballea, Samuel, Toumi, Mondher, Boyer, Laurent, Fond, Guillaume
Publikováno v:
In eClinicalMedicine March 2024 69
Autor:
Damien Etchecopar-Etchart, Dong Keon Yon, Piotr Wojciechowski, Samuel Aballea, Mondher Toumi, Laurent Boyer, Guillaume Fond
Publikováno v:
EClinicalMedicine, Vol 69, Iss , Pp 102473- (2024)
Summary: Background: Antipsychotics are the gold standard treatment for schizophrenia, but many patients who receive treatment experience persistent symptoms. The aim of this network meta-analysis was to determine the efficacy of augmentation drugs f
Externí odkaz:
https://doaj.org/article/528cefcb95694d499b63a76bd468e038
Autor:
J. Shen, E. Kharitonova, S. Biswal, M. Sharma, S. Aballea, A. Tytuła, J. Zawieja, P. Towle, R. Hanley
Publikováno v:
International Journal of Infectious Diseases, Vol 130, Iss , Pp S141- (2023)
Intro: Dengue, a vector-borne disease, is a global threat to public health with incidence increased from 0.5 to 5.2 million cases between 2010 and 2019. Data collected over ∼57 months of the phase-3 DEN-301 trial of the candidate vaccine (TAK-003)
Externí odkaz:
https://doaj.org/article/4b226e49ee53429ca03ebe807f3325bb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bebrysz, Magdalena *, Wright, Andrea, Greaves, Michelle, Rathwell Deault, Dominick, Hopkins, Gemma, Gildea, Edwina, Aballéa, Samuel
Publikováno v:
In Preventive Veterinary Medicine November 2021 196
Publikováno v:
In Public Health September 2021 198:230-237
Publikováno v:
In Public Health May 2021 194:135-142
Autor:
Skrzeczek, Aleksandra, Ikeoka, Hidetoshi, Hirotsu, Nobuo, Ansaripour, Amir, Aballéa, Samuel, Onishi, Yoshie, Hill, Mark, Igarashi, Ataru
Publikováno v:
In Journal of Infection and Chemotherapy February 2021 27(2):296-305
Autor:
Vanessa Taieb, Hidetoshi Ikeoka, Fang-Fang Ma, Katarzyna Borkowska, Samuel Aballea, Keiko Tone, Nobuo Hirotsu
Publikováno v:
Терапевтический архив, Vol 92, Iss 11, Pp 122-131 (2020)
Aim. Baloxavir marboxil (baloxavir) is the first cap-dependent endonuclease inhibitor being studied for the treatment of influenza in single oral dosing regimen. This network meta-analysis (NMA) evaluated the efficacy and safety of baloxavir compared
Externí odkaz:
https://doaj.org/article/c3fbf548203e465baa7d80afee4ebbf0